Home › Funds › Victory Capital › Victory Science & Technology Fund
Fund family: Victory Capital · Filed by VICTORY PORTFOLIOS III (CIK 908695) · SEC series S000012911
Share classes and tickers: USSCX (C000034880), USTCX (C000220624)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,563 with, 92 against, 1 abstentions (not counted as with management); 2 items carried no recommendation; 10 split votes are in neither count. Shareholder proposals: 28 FOR, 57 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Victory Capital’s manager page (160,780 ballot items across 92 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Victory Capital | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 90.8% | 1,473 | 93.2% | 139,221 |
| Backed environmental and social shareholder proposals at US companies | 11.5% | 52 | 4.4% | 2,755 |
Each ballot item this fund voted is set against the votes of the other Victory Capital funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Victory Capital funds on 28 items (3.1% of the 902 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Victory Capital funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Company | 2026-05-05 | Shareholder Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director | For | AGAINST — 27 of 27 Victory Capital funds | Against | Not approved, 27.6% support |
| Bristol-Myers Squibb Company | 2026-05-05 | Election of Directors: Derica W. Rice | Against | FOR — 27 of 27 Victory Capital funds | Against | Elected, 97.2% support |
| NetApp, Inc. | 2025-09-10 | To approve an amendment to NetApp's 2021 Equity Incentive Plan. | For | AGAINST — 26 of 26 Victory Capital funds | For | Approved, 68.0% support |
| CVS Health Corporation | 2026-05-14 | Shareholder Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. | Against | FOR — 22 of 22 Victory Capital funds | For | — |
| Oracle Corporation | 2025-11-18 | Advisory Vote to Approve the Compensation of our Named Executive Officers | For | AGAINST — 18 of 18 Victory Capital funds | For | Passed (calculated), 81.9% support |
| Advanced Micro Devices, Inc. | 2026-05-13 | Election of Directors: Abhi Y. Talwalkar | Against | FOR — 15 of 15 Victory Capital funds | Against | Passed (calculated), 91.7% support |
| Autodesk, Inc. | 2026-06-17 | Election of Directors: John T. Cahill | Against | FOR — 13 of 13 Victory Capital funds | Against | Passed (calculated), 94.7% support |
| Autodesk, Inc. | 2026-06-17 | Approval of an amendment of our Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law. | Against | FOR — 12 of 12 Victory Capital funds | Against | Passed (calculated), 81.5% support |
| Datadog, Inc. | 2026-06-15 | To elect four Class I directors, each to hold office until our Annual Meeting of Stockholders in 2029: Dev Ittycheria | For | WITHHOLD — 10 of 10 Victory Capital funds | For | Elected, 88.8% support |
| Datadog, Inc. | 2026-06-15 | To elect four Class I directors, each to hold office until our Annual Meeting of Stockholders in 2029: Shardul Shah | For | WITHHOLD — 10 of 10 Victory Capital funds | For | Elected, 83.8% support |
| United Therapeutics Corporation | 2026-06-26 | Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan. | For | AGAINST — 10 of 10 Victory Capital funds | For | Passed (calculated), 72.0% support |
| Incyte Corporation | 2026-06-08 | Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Julian C. Baker | Against | FOR — 10 of 10 Victory Capital funds | Against | Elected, 80.9% support |
| Zscaler, Inc. | 2026-01-12 | To approve on a non-binding, advisory basis, the compensation of our named executive officers. | Against | FOR — 9 of 9 Victory Capital funds | Against | Approved, 93.2% support |
| CrowdStrike Holdings, Inc. | 2026-06-17 | To approve an amendment and restatement of CrowdStrike's amended and restated certificate of incorporation to limit officer liability as permitted by Delaware law. | Against | FOR — 8 of 8 Victory Capital funds | Against | Approved, 85.4% support |
| Shopify Inc. | 2026-06-16 | Election of Director: Fidji Simo | Against | FOR — 8 of 8 Victory Capital funds | Against | Elected, 96.7% support |
| Danaher Corporation | 2026-05-05 | To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders | For | AGAINST — 6 of 6 Victory Capital funds | For | Elected, 73.8% support |
| Danaher Corporation | 2026-05-05 | To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri L. List | For | AGAINST — 6 of 6 Victory Capital funds | For | Elected, 77.7% support |
| Regeneron Pharmaceuticals, Inc. | 2026-06-12 | Election of Directors: Christine A. Poon | For | AGAINST — 9 of 10 Victory Capital funds | For | Elected, 76.8% support |
| Regeneron Pharmaceuticals, Inc. | 2026-06-12 | Election of Directors: Craig B. Thompson, M.D. | For | AGAINST — 9 of 10 Victory Capital funds | For | Elected, 79.3% support |
| Regeneron Pharmaceuticals, Inc. | 2026-06-12 | Election of Directors: Joseph L. Goldstein, M.D. | For | AGAINST — 9 of 10 Victory Capital funds | For | Elected, 70.1% support |
| Boston Scientific Corporation | 2026-04-30 | Proposal to elect ten Directors: David C. Habiger | Against | FOR — 5 of 5 Victory Capital funds | Against | Elected, 85.9% support |
| MKS Inc. | 2026-05-11 | The approval, on an advisory basis, of a Company proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 25%. | Abstain | FOR — 4 of 4 Victory Capital funds | Against | Passed (calculated), 98.5% support |
| Scholar Rock Holding Corporation | 2026-06-04 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. | For | AGAINST — 4 of 4 Victory Capital funds | For | Approved, 61.7% support |
| Stoke Therapeutics, Inc | 2026-06-03 | To approve, on an advisory basis, the compensation of the Company's named executive officers. | For | AGAINST — 4 of 4 Victory Capital funds | For | Passed (calculated), 72.9% support |
| Bio-Techne Corporation | 2025-10-30 | Approve, on an advisory basis, the compensation of our executive officers. | For | AGAINST — 3 of 3 Victory Capital funds | For | Approved, 72.1% support |
| Company | Meeting | Item | This fund | Most Victory Capital funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. | 2026-06-17 | Re-election of Class I directors: Julian Baker | Withhold | FOR — 3 of 3 Victory Capital funds | Against | Elected, 88.6% support |
| Dianthus Therapeutics, Inc. | 2026-05-21 | To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorge | For | WITHHOLD — 3 of 3 Victory Capital funds | For | Passed (calculated), 80.6% support |
| Mineralys Therapeutics, Inc. | 2026-05-21 | 2 wordings Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Srinivas Akkaraju, M.D., Ph.D. | For | WITHHOLD — 3 of 3 Victory Capital funds | For | Passed (calculated), 60.6% support |
Download all 28 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 82.4% of this fund’s 1,656 such votes could be given a sector; the other 291 (17.6%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 612 | 19 | 3.1% |
| Technology | 542 | 56 | 10.3% |
| Consumer Discretionary | 83 | 14 | 16.9% |
| Industrials | 78 | 2 | 2.6% |
| Consumer Staples | 17 | 1 | 5.9% |
| Finance | 11 | 0 | 0.0% |
| Miscellaneous | 11 | 0 | 0.0% |
| Telecommunications | 7 | 0 | 0.0% |
| Utilities | 4 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 1,037 | 5 |
| Audit-related | 168 | 0 |
| Say-on-Pay | 144 | 1 |
| Corporate Governance | 97 | 12 |
| Compensation | 87 | 4 |
| Capital Structure | 63 | 3 |
| Other Social Issues | 29 | 26 |
| Shareholder Rights and Defenses | 28 | 15 |
| Human Rights or Human Capital/workforce | 11 | 11 |
| Environment or Climate | 8 | 8 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Meta Platforms, Inc. | May 27, 2026 | $96M | 37 | 11 |
| NVIDIA Corporation | June 24, 2026 | $85M | 26 | 4 |
| Microsoft Corporation | December 5, 2025 | $79M | 24 | 8 |
| Amazon.com, Inc. | May 20, 2026 | $47M | 17 | 4 |
| Guardant Health, Inc. | June 17, 2026 | $32M | 5 | 0 |
| MACOM Technology Solutions Holdings, Inc. | March 5, 2026 | $31M | 10 | 0 |
| Coherent Corp. | November 13, 2025 | $31M | 12 | 0 |
| AppLovin Corporation | June 3, 2026 | $31M | 19 | 3 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding report on Al data usage oversight. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | Report on Risks of Censorship in Generative Artificial Intelligence Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | Shareholder Proposal Requesting A Report On Charitable Partnerships Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | Shareholder Proposal Requesting Additional Reporting On Impact Of Data Centers On Climate Commitments Shareholder proposal | Against | For |
| June 3, 2026 | AppLovin Corporation | Election of Directors: Adam Foroughi | Withhold | For |
| June 3, 2026 | AppLovin Corporation | Election of Directors: Eduardo Vivas | Withhold | For |
| January 27, 2026 | Visa Inc. | Shareholder proposal on report on online sexual exploitation. Shareholder proposal | Against | For |
| January 27, 2026 | Visa Inc. | Shareholder proposal on inclusion ROI audit. Shareholder proposal | Against | For |
1,681 ballot items at 166 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Victory Science & Technology Fund (USSCX) voted at 166 shareholder meetings of 159 companies, on 1,681 ballot items in all. Where management made a recommendation, the fund followed it on 94.4% of the items and voted against it 92 times. Its most frequent area of disagreement was other social issues (26 of its votes against management). It voted FOR 32.9% of the 85 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than Victory Capital's funds as a whole (90.8% against 93.2%). It voted differently from most Victory Capital funds on 28 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Victory Capital’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.